|
Jun 14
|
1 Growth Stock Down 9% to Buy Right Now
|
|
Jun 13
|
Top Analyst Reports for Eli Lilly, Home Depot & SAP
|
|
Jun 13
|
Novo Nordisk Is Europe’s Most Valuable Company—Again. Eli Lilly, Watch Out.
|
|
Jun 13
|
Lilly Moves Past 50-Day Average: Should You Buy the Stock Now?
|
|
Jun 13
|
Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump
|
|
Jun 13
|
NVO Stock up on Plans to Advance Obesity Candidate Amycretin
|
|
Jun 13
|
Down 12%, Should You Buy the Dip on Eli Lilly?
|
|
Jun 12
|
Abbott Laboratories Stock Sees RS Rating Rise To 82
|
|
Jun 11
|
Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 11
|
Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
|
|
Jun 11
|
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
|
|
Jun 11
|
Should You Buy Eli Lilly Stock Before June 22?
|
|
Jun 11
|
The cheap fat jabs sending big pharma into a frenzy
|
|
Jun 10
|
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
|
|
Jun 10
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Jun 10
|
Hims & Hers stock falls after Lilly rules out partnership
|
|
Jun 10
|
Update: Market Chatter: Lilly to Only Work With Telehealth Companies That Don't Sell Copycat Zepbound
|
|
Jun 10
|
Drug pricing reform talks with US government lack clarity, industry executives say
|
|
Jun 10
|
Sector Update: Health Care Stocks Higher Tuesday Afternoon
|